1) Introduction; T. Dittmar, K.S. Zänker

Bone marrow-derived stem cells

2) Hematopoietic stem and progenitor cells in clinical use - transplantation and mobilization; M. Punzel

3) Ex-vivo Expansion of HSPCs; Y. Wei

4) Modulation of hematopoietic stem/progenitor migration; T. Dittmar5) Properties of mesenchymal stem cells to consider for cancer cell therapy; J. Stagg

Embryonic stem cells

6) Alternative embryonic stem cell sources; T. Saric, J. Hescheler\n7) Cell therapy in Parkinson\'s Disease; R. Laguna Goya, R. A. Barker

8) Transplantation of stem cells and their derivatives in the treatment of multiple sclerosis; E. Larsen, I. Duncan\nCancer Stem Cells

9) Cancer - A Stem Cell-based disease?; J. E. Trosko

10) Stem Cell Niche vs. Cancer Stem Cell Niche - Differences and Similarities; B. C. Baguley, G. J. Finlay

11) The chronically inflamed microenvironment and cancer stem cells; H. Li, C. Stoicov, X. Fan, J. Cerny, J.M. Houghton

12) Does the chronically inflamed periodontium harbour cancer stem cells?; W.-D. Grimm, W. H. Arnold, S. Becher, A. Dannan, G. Gassmann, S. Philippou, T. Dittmar, G. Varga

13) Cancer Stem Cells in the Haematopoietic System/ Haematopoietic Stem/ Progenitor Cell Disorders; M. Müschen

14) Cancer stem cells in solid tumors; M. G. Nafus, A. Y.Nikitin

15) \'One for all\' or \'All for one\'? - The necessity of cancer stem cell diversity in metastasis formation and cancer relapse; T. Dittmar, C. Nagler, S. Schwitalla, K. Krause, J. Seidel, G. Reith, B. Niggemann, K. S. Zänker

16) Elimination of Cancer Stem Cells; A. Sagrera, J. Pérez-Losada, M. Pérez-Caro, R. Jiménez, I. Sánchez-García, C. Cobaleda

17) Potential molecular therapeutic targets in cancer stem/progenitor cells: Are ATP-binding cassette membrane transporters appropriate targets to eliminate cancer-initiating cells?; M. Mimeault, S. K. Batra